David Korn is presently Consultant in Pathology at the Massachusetts General Hospital and Professor of Pathology at Harvard Medical School. From November 15, 2008 to June 30, 2011, he was the inaugural Vice-Provost for Research at Harvard University. Prior to joining Harvard, Dr. Korn had served as the Chief Scientific Officer of the Association of American Medical Colleges (AAMC) in Washington, D.C. since January 15, 2007, and before that as the Senior Vice President for Biomedical and Health Sciences Research at the Association since September 1, 1997.
Dr. Korn served as Carl and Elizabeth Naumann Professor and Dean of the Stanford University School of Medicine from October 1984 to April 1995, and as Vice President of Stanford University from January 1986 to April 1995. Previously, he had served as Professor and Founding Chairman of the Department of Pathology at Stanford, and Chief of the Pathology Service at the Stanford University Hospital, since June 1968. Dr. Korn has been Chairman of the Stanford University Committee on Research; President of the American Association of Pathologists (now the American Society for Investigative Pathology), from which he received the Gold-Headed Cane Award for lifetime achievement in 2004; President of the Association of Pathology Chairman, from which he received the Distinguished Service Award in 1999; a member of the Board of Directors and of the Executive Committee of the Federation of American Societies for Experimental Biology; and a member of the Board of Directors of the Association of Academic Health Centers.
Dr. Korn has been a member of the editorial boards of the American Journal of Pathology, the Journal of Biological Chemistry, and Human Pathology, and for many years was an Associate Editor of the latter. He has served on many Society Councils and Boards. His more than 160 publications range from bacteriophage biochemistry and genetics to the biochemistry and molecular biology of DNA replication in human cells, and more recently, focus on issues of academic values and integrity, research integrity, health and science policy, and financial conflicts of interest in academic medicine.